EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DICICCO WENDY F

SEC · Aug 22 04:36

Summary by Futu AI

Wendy F. DiCicco, associated with EyePoint Pharmaceuticals, Inc., completed a purchase of 2,567 shares of common stock on August 20, 2024. The transaction was carried out in the open market at a price of $7.79 per share. Following this acquisition, DiCicco's direct holdings in the company increased to a total of 9,967 shares of common stock.

Helpful

Not Helpful

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DICICCO WENDY F

Risk Disclaimer